RxDoctor Payments Data

Timothy McClure, MD

Vascular & Interventional Radiology · New York, NYNPI 1992977342

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $91,201 of the $117,391 with a category attached, or 77.7%. 23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 29.3% of the total. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$117,391in general payments, 2019–2025

Across 142 payments — averaging $826.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$34K
  • Boston Scientific$19K
  • Telix Pharmaceuticals$18K
  • Janssen Research & Development, LLC$14K
  • GE HealthCare$13K
  • Johnson & Johnson$7K
  • plus $13K from 17 others
$573,257in research payments, 2019–2025

Across 28 payments — averaging $20,473 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Angiodynamics, Inc.$451K
  • Progenics Pharmaceuticals, Inc.$122K

What the payments were for

  • Consulting fees$91,20178%
  • Speaking & faculty fees$1,1001%
  • Travel & lodging$18,26016%
  • Food & beverage$6,8296%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$117,391 in reported general payments places this provider in the 90th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$179,620
Medicare patients
523
Services billed
1,267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →